MLNT Paul Estrem bought MELINTA THERAPEUTICS, INC. /NEW/ shares — SEC Form 4BUYMELINTA THERAPEUTICS, INC. /NEW/

Paul Estrem, Chief Financial Officer at MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), bought 10,000 shares at $5.00 ($50K) on 2018-05-29, disclosed to the SEC on 2018-05-31.

SEC EDGAR Filing

0000899243-18-014568

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Strong74/100

Clearly above the average filing.

First-Time BuyerBuying the DipOpportunistic BuyDeep Dip Buy

Trade Context

•6 other insiders also purchased in last 30 days
•Stock down -63% in previous 6 months

Filing Info

Filed2018-05-31

Traded2018-05-29

Accession0000899243-18-014568

SourceSEC EDGAR (Historical)

Insider

NamePaul Estrem

TitleChief Financial Officer

PIT GradeInsiderUnrated

View Company View Insider

Get an email when an insider at MLNT files

Free account. Follow MLNT and up to 10 more companies.

Follow MLNT for free

MLNT Paul Estrem bought MELINTA THERAPEUTICS, INC. /NEW/ shares — SEC Form 4BUYMELINTA THERAPEUTICS, INC. /NEW/

Trade Context

Filing Info

Insider

Trade Details

Outcomes